
SCIENTIFIC SYMPOSIUM
2022 Harrington
Scientific Symposium
May 25-26, 2022
** Plenary sessions for the Symposium will be broadcast in this space. No additional access links are needed. **

Have a question? Email Questions@HarringtonDiscovery.org
Need assistance logging in? Call 216-514-5023
Private Scholar Presentation Session: www.HDIEvents.org/ProjectPresentations
Password will be emailed to participants of this session.
2022 SCIENTIFIC SYMPOSIUM AGENDA
MAY 25 - MAY 26
* Note: Meeting will be held in Eastern Time zone.
Wednesday, May 25 - Day One
Plenary Session: 10:00am – 12:15pm ET OPEN TO ALL GUESTS
Private Session: 12:30pm – 3:00pm ET CLOSED SESSION (Scholars, Partners, Advisors only)
10:00am –10:15am
Welcome
Jonathan S. Stamler, MD
President, Harrington Discovery Institute
Robert S. & Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation
Introduction to Ronald G. Harrington
Daniel I. Simon, MD
President, Academic & External Affairs and Chief Clinical & Scientific Officer, University Hospitals
Ernie and Patti Novak Distinguished Chair in Health Care Leadership at University Hospitals
Remarks
Ronald G. Harrington
Philanthropist and Entrepreneur
10:15am –10:50am
Introduction to Keynote Address
Jonathan S. Stamler, MD
Keynote Address
Jeffrey Leiden, MD, PhD
Title: Discovering Transformative Medicines: The Vertex Innovation Model
Executive Chairman, Vertex Pharmaceuticals
10:50am –11:00am
Introduction of Cliff Megerian, MD
Jonathan S. Stamler, MD
UH Remarks
Cliff A. Megerian, MD, FACS
CEO, University Hospitals
Jane and Henry Meyer Chief Executive Officer Distinguished Chair
11:00am –11:45am
The Harrington Impact on Alzheimer’s Disease:
Novel Pathways and Therapies
Moderator:
Andrew Pieper, MD, PhD
Director, Center for Brain Health Medicines, Harrington Discovery Institute
Investigator, Harrington Discovery Institute
Morley-Mather Chair in Neuropsychiatry
Panel Members:
Jerri Rook, PhD
Vanderbilt University
2015 ADDF-Harrington Scholar
Stephen Strittmatter, MD, PhD
Yale University
2020 Harrington Scholar-Innovator
Jonathan Stamler, MD
Case Western Reserve University / University Hospitals
11:45am –12:10pm
Introduction of 2022 Harrington Prize Recipients
Hossein Ardehali, MD, PhD
Northwestern University
President, American Society for Clinical Investigation
2022 Harrington Prize Remarks
James Crowe, MD
Vanderbilt University
Michel Nussenzweig, MD, PhD
The Rockefeller University
12:15pm –12:30pm
BREAK & END OF DAY 1 PLENARY SESSION
Scholar Scientific Presentations are delivered in a Closed Session.
Scholars, Partners, Advisors only.
12:30pm –12:35pm
Introduction to Scholar Presentations and Advisory Panels
Moderator:
Seth Field, MD, PhD
Director, Physician-Scientist Programs
Investigator, Harrington Discovery Institute
12:35pm –3:00pm
Rizwan Haq, MD, PhD
Title: A Small Molecule that Targets Cancers with Dysregulated KEAP-NRF2 Signaling
2020 Harrington Scholar-Innovator
Dana-Farber Cancer Institute
Jill Smith, MD
Title: Targeted Nanoparticle for Early Diagnosis and Treatment of Pancreatic Cancer
2021 Harrington Scholar-Innovator
Georgetown University
Joseph Contessa, MD, PhD
Title: Development of OST Inhibitors for the Treatment of Lung Cancer
2021 Harrington Scholar-Innovator
Yale University
John Chorba, MD
Title: Inhibiting PCSK9 Self-Proteolysis to Treat Atherosclerosis
2021 Harrington Scholar-Innovator
University of California, San Francisco
Kyu Rhee, MD, PhD
Title: Pantothenamides Against Tuberculosis: Selective Inhibitors of the Mycobacterium Tuberculosis Tubercle
2020 Harrington Scholar-Innovator
Weill Cornell Medicine
Jennifer Chen, MD
Title: Targeting Acid Ceramidase to Reverse Fibrosis
2021 Harrington Scholar-Innovator
University of California, San Francisco
Aaron Schimmer, MD
Title: Development of Novel Inhibitors of Human Mitochondrial Protease, ClpP
2021 Harrington Scholar-Innovator
University of Toronto
3:00pm
Day 1 Closing Remarks
Seth Field, MD, PhD
Thursday, May 26 - Day Two
Plenary Session: 10:00am – 11:30am ET OPEN TO ALL GUESTS
Private Session: 12:00pm – 2:10pm ET CLOSED SESSION (Scholars, Partners, Advisors only)
10:00am –10:10am
Welcome Back
Seth Field, MD, PhD
Director, Physician-Scientist Programs
Investigator, Harrington Discovery Institute
10:10am –10:35am
Introduction to Scholar Experience Presentations
Diana Wetmore, PhD
Vice President of Therapeutics Development, Harrington Discovery Institute
Rosa Bacchetta, MD
Stanford University
2019 Harrington Scholar-Innovator
Marc Wein, MD, PhD
Massachusetts General Hospital
2018 Harrington Scholar-Innovator
10:35am –11:25am
Introduction to Panel Session
Lenka Fedorkova, PhD
Vice President, Business Development and Strategic Alliance Management
Creating a Value Proposition that Attracts Investment:
A Panel Session with Harrington Investment Advisors
Moderator:
Rebecca Braun
Consultant, Harrington Discovery Institute
Panel Members:
Graeme Martin, PhD
Chief Investment Officer, ALSA Ventures
Member, Harrington Discovery Institute Investment Advisory Board
John Rice, PhD
Life Sciences Managing Director, CincyTech, LLC.
Chair, Harrington Discovery Institute Investment Advisory Board
Jesse Treu, PhD
Partner Emeritus, Domain Associates
Member, Harrington Discovery Institute Investment Advisory Board
11:25am –12:00pm
BREAK & END OF DAY 2 PLENARY SESSION
Scholar Scientific Presentations are delivered in a Closed Session.
Scholars, Partners, Advisors only.
12:00pm –12:05pm
Introduction to Scholar Presentations and Advisory Panels
Moderators:
Andrew Pieper, MD, PhD
Director, Center for Brain Health Medicines, Harrington Discovery Institute
Investigator, Harrington Discovery Institute
Morley-Mather Chair in Neuropsychiatry
Atul Chopra, MD, PhD
Investigator, Harrington Discovery Institute
12:05pm –2:10pm
Stephen Martin, PhD
Title: New Approach for Neuroprotection of Photoreceptors by Targeting TMEM97/σ2R
2019 Gund Harrington Scholar
University of Texas at Austin
Donald Weaver, MD, PhD, FRCP(C)
Title: Design and Development of Small Molecular Therapeutics Targeting the Immunopathy of Alzheimer’s Disease
2020 Harrington Scholar-Innovator
University Health Network
Xinnan Wang, MD, PhD
Title: Targeting Mitophagy for Treating Parkinson’s Disease
2021 Harrington Scholar-Innovator
Stanford University
Timothy Yu, MD, PhD
Title: ASO Treatment for KCNT1-Associated Developmental Epileptic Encephalopathy
2020 Harrington Scholar-Innovator
Boston Children's Hospital
Michael Holtzman, MD
Title: A New Drug to Correct Epithelial Stem Cell Reprogramming in Respiratory Disease
2020 Harrington Scholar-Innovator
Washington University St. Louis
Toren Finkel, MD, PhD
Title: Generating Small Molecules that Boost NAD+ Levels for Age-Related Diseases
2021 Harrington Scholar-Innovator
University of Pittsburgh
2:10pm
Day 2 Closing Remarks
Jonathan S. Stamler, MD
President, Harrington Discovery Institute